Stock UniverseDerived research view · source repositories remain read-only

Equillium, Inc. (EQ)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
20.80
Global Rank
3260
Market Cap
110.83M
Latest Close
2.94
RS Composite
67.82% · G#87

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
35.48%
3M
66.10%
6M
237.93%
1Y
694.59%
3Y
374.19%
5Y
-55.18%
10Y
-79.00%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 1.14M · 30-day average: 804.27K · Max drawdown over stored range: -98.91%

Research Snapshot

Relative Strength vs SPX

RS Composite67.82%
20D RS36.75%
60D RS38.77%
120D RS112.41%
Global RS Rank87 · 97.41% percentile
Watch+Speculative RS Rank46 · 97.81% percentile
Group ScopeWatch+Speculative
Primary RS Rank15 · 96.72% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank431 / 701
Primary Percentile38.66
Score Notesmarket-cap support, industry-tailwind, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for EQ.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue0015.75936.08441.095
Revenue Growth (YoY)3000%3000%3000%128.974%13.887%
Gross Profit0015.75936.08441.095
Operating Income-29.548-37.786-39.027-14.522-8.269
Free Cash Flow-24.826-32.138-9.012-21.833-19.111-22.794
Free Cash Flow Per Share-1.22-1.116-0.267-0.629-0.541-0.3977720229523915
EPS (Diluted) GAAP-1.464613-1.355675-1.850928-0.384001-0.228154
EPS Growth
EPS Non-GAAP
Gross Margin3000%3000%100%100%100%
Operating Margin3000%3000%-247.649%-40.245%-20.122%
Profit Margin3000%3000%-396.142%-36.955%-19.63%
Free Cash Flow Margin3000%3000%-57.186%-60.506%-46.504%
Shares Outstanding (Diluted)20.355528.806333.727934.726435.357657.3042
Shares Change (YoY)17.133%41.516%17.085%2.96%1.818%62.07%

SEC Quarterly Fundamentals

No processed quarterly rows for EQ.